Introduction
Bladder cancer is the most common cause of macroscopic haematuria in the over 40 year age group in Sri Lanka [1] . Delay in initiating treatment may have a profound effect on the survival rate in patients with bladder cancer [2] . In the present study, we investigated the delay between the onset of symptoms and commencement of treatment in patients with macroscopic haematuria in whom it was the presenting symptom, with emphasis on bladder cancer.
Patients and methods
Between 1 January 2002 and 31 December 2002, 106 consecutive new patients with macroscopic haematuria as the presenting symptom, were prospectively evaluated in our unit. All patients were evaluated with a detailed history, physical examination and appropriate investigations.
We used the following definitions: Patient delay is the time (days) between first notice of haematuria and seeking medical advice. Doctor delay is the time (months) between the first consultation and the patient's first visit to the urologist at the hospital. Hospital delay is the time (days) between the first urological To the Editor:
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consultation and the first definitive treatment for the disease. We determined the hospital delay only for bladder cancer patients.
Results
In all, 106 patients were identified with macroscopic haematuria during the 12-month period (86 males). There were 73 patients over the age of 40 years and 33 under the age of 40. The mean age was 51.6 years (range 4-94 years, SD 16.5). Fifty eight (54.7%) patients had painless haematuria and 48 (45.3%) patients presented with painful haematuria. The mean duration of haematuria was 7.5 months (range 1 day to 5 years).
The causes of macroscopic haematuria in our study are given in Table 1 . Bladder cancer was the most common cause (42.5%) of macroscopic haematuria in the over 40 year age group. Thirty six (34.0%) patients reported to their doctors on the first day of haematuria. The median patient delay was 14 days (mean 15.3 ; range 1-330). Patient delay for bladder cancer had a median of 12 days (mean 28.6; range 1-330). Seven of 32 bladder cancer patients reported to their doctor on the first day of haematuria. Doctor delay is shown in Table 2 . Median hospital delay for bladder cancer patients was 7 days (mean 5; range 1-22) 
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Discussion
Macroscopic haematuria is an alarming symptom to a patient, necessitating immediate medical attention. In the present series, bladder cancer was the predominant cause of macroscopic haematuria, affecting 30.2% of patients. In the over 40 year age group it accounted for 42.5% of patients with macroscopic haematuria.
The total delay from first onset of symptoms to first treatment can be divided into patient delay, doctor delay and hospital delay. Patients in the UK usually present to their general practitioner (GP) soon after the onset of symptoms (most within one week) and are rapidly referred to a hospital [2, 4] . The West Midlands Urological Research Group study found a significantly better survival for patients referred to a hospital within 14 days of the onset of symptoms [3] . In the present study, 34% of patients with macroscopic haematuria reported to their doctors on the first day of noticing haematuria and the median patient delay was only 14 days. Hence, the patient delay is not a significant contributory factor for the total delay in Sri Lanka. The 47% of patients in this study reported to their GP with the complaint of macroscopic haematuria, and 26% of these patients were found to have bladder cancer. The median GP delay of 3.5 months is unacceptably long.
In the UK, hospital delay is the most significant cause of the total delay in the diagnosis and definitive treatment of patients with bladder cancer [3] [4] [5] . The median hospital delay was 68 days in the West Midlands study [3] . Our unit's policy of fast-tracking haematuria patients over 40 years of age for cystoscopic evaluation, disregarding waiting time, is responsible for the extremely short hospital delay (median 7 days) for bladder cancer.
Most patients in this series reported to their doctors promptly, one third on the first day of haematuria. The long doctor delay may reflect a failure to recognize macroscopic haematuria as a characteristic feature of urological cancer and urolithiasis, and that delay in the diagnosis of malignancy worsens prognosis.
